
|Articles|June 29, 2012
Schizophrenia Pharmacotherapy: What Role for Perphenazine? (Video 1:39 minutes)
Author(s)Peter F. Buckley, MD
In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.
Advertisement
In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.
Perphenazine was used in the CATIE study. Here, Dr. Peter Buckley addresses:
• The current role of perphenazine in the management of schizophrenia.
• The drug’s association with weight gain.
• The metabolic side effect profile of perphenazine.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Advertisement
Advertisement
Trending on Psychiatric Times
1
Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia
2
AI in 2025: A Look Back With Allen Frances, MD
3
Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics
4
Latest Alzheimer Disease Data: Reports from CTAD 2025
5




